SCHEMBL304127

SCHEMBL304127

CCOC(=O)OCC(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
SOAT1 P35610 1/20 0.52
TSHR P16473 4/20 0.46
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
NFKB1 P19838 1/20 0.43
PTGS1 P23219 1/20 0.43
APEX1 P27695 1/20 0.43
THPO P40225 1/20 0.43
PMP22 Q01453 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27608633 0.91 SOAT1 (0.68) ALDH1A1SOAT1TSHRLMNAMEN1
SCHEMBL25435787 0.89 TSHR (0.54) ALDH1A1TSHRLMNAMEN1CYP3A4
SCHEMBL37351 0.89 TSHR (0.54) ALDH1A1TSHRLMNAMEN1CYP3A4
Acetic Acid Isobutyl Ester SCHEMBL28253103 0.89 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1
Ammonia Solution, Strong SCHEMBL9998248 0.87 TSHR (0.52) ALDH1A1TSHRLMNAMEN1CYP3A4
SCHEMBL12310710 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1
SCHEMBL12310709 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1
SCHEMBL1469075 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1
SCHEMBL1717365 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1
SCHEMBL1470043 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1TSHRLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 836 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122025799-A High-voltage-resistant electrolyte, preparation method, application and potassium ion battery 北京航空航天大学 2026-05-12 CN claimed
WO-2025118244-A1 SECONDARY BATTERY AND ELECTRONIC APPARATUS 东莞新能源科技有限公司 2025-06-12 WO claimed
WO-2025118241-A1 SECONDARY BATTERY AND ELECTRONIC DEVICE 宁德新能源科技有限公司 2025-06-12 WO claimed
US-20250174725-A1 SECONDARY BATTERY AND ELECTRONIC APPARATUS DONGGUAN AMPEREX TECHNOLOGY LIMITED (CN) 2025-05-29 US claimed
EP-4560766-A2 SECONDARY BATTERY AND ELECTRONIC APPARATUS Dongguan Amperex Technology Limited (CN) 2025-05-28 EP claimed
WO-2025050890-A9 SECONDARY BATTERY AND ELECTRONIC APPARATUS 宁德新能源科技有限公司 2025-05-15 WO claimed
WO-2025066613-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE USING SAME, AND ELECTRONIC DEVICE 宁德新能源科技有限公司 2025-04-03 WO claimed
WO-2025050890-A1 SECONDARY BATTERY AND ELECTRONIC APPARATUS 宁德新能源科技有限公司 2025-03-13 WO claimed
US-20240332620-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-03 US claimed
EP-4439728-A2 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS Ningde Amperex Technology Ltd. (CN) 2024-10-02 EP claimed
EP-2189443-B1 TRICYCLIC AMIDE COMPOUND RES FOUND ITSUU LAB (JP) 2013-10-23 EP claimed
US-7687490-B2 2-thioethenyl substituted carbapenem derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2010-03-30 US claimed
EP-1870412-A1 2-THIOETHENYL CARBAPENEM DERIVATIVE MEIJI SEIKA KAISHA LTD. (JP) 2007-12-26 EP claimed
US-20070004700-A1 2-Thioethenyl substituted carbapenem derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2007-01-04 US claimed
US-5616600-A Griseolic acid compounds and their use as a phosphodiesterase inhibitor SANKYO COMPANY, LIMITED (JP) 1997-04-01 US claimed
US-5491167-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY, LIMITED (JP) 1996-02-13 US claimed
US-5480987-A 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them AMERICAN CYANAMID COMPANY (US) 1996-01-02 US claimed
US-5369102-A B-lactamase inhibitors AMERICAN CYANAMID COMPANY (US) 1994-11-29 US claimed
EP-0478874-A2 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them AMERICAN CYANAMID COMPANY (US) 1992-04-08 EP claimed
US-5068232-A Bactericides AMERICAN CYANAMID COMPANY (US) 1991-11-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004700-A1 2-Thioethenyl substituted carbapenem derivatives MTAP, BLVRB, BPGM ALDH1A1 1182/4885SOAT1 3551/4885TSHR 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.